Literature DB >> 23117327

Coronary to bronchial artery fistula: are we treating it right?

Luiz Fernando Ybarra1, Henrique B Ribeiro, Whady Hueb.   

Abstract

Fistulas between coronary artery and bronchial artery may be present from birth, with few hemodynamic consequences, and may remain closed due to similarity of the filling pressures at these 2 sites. They can also be secondary to pulmonary artery occlusive disease or chronic pulmonary inflammation. These pulmonary changes may cause a dilation of the fistula and make it functional, causing angina pectoris by coronary steal syndrome, which is the most common symptom. The presentation may also be composed of episodes of hemoptysis, heart failure, and infective endocarditis. However, most patients remain asymptomatic. The ones that need treatment may not have a good response to the medical management, requiring an intervention. This can be done using embolization coils, stents grafts, and performing surgical ligation of the fistulas.

Entities:  

Mesh:

Year:  2012        PMID: 23117327

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  3 in total

1.  Atypical chest pain due to multiple coronary arteries fistulas occluded with percutaneous interlock coils: A case report.

Authors:  Gustavo Iacomini Ida; Michel A Kalansky; Luciana de Pádua S Baptista; Pedro Gabriel Melo de Barros E Silva; Marcelo Jamus; José Carlos Teixeira Garcia; Valter Furlan; Expedito E Ribeiro; Henrique B Ribeiro
Journal:  J Cardiol Cases       Date:  2020-09-11

2.  Takayasu Arteritis with Multiple Coronary Artery Fistulas to Bronchial Arteries.

Authors:  Kanber Ocal Karabay; Emine Altuntas; Ender Uysal; Ahmet Ozkara; Vedat Aytekin
Journal:  Int J Angiol       Date:  2013-07-02

3.  Coronary artery-bronchial artery fistulas: report of two Dutch cases with a review of the literature.

Authors:  S A M Said; R M Oortman; J-H Hofstra; P M J Verhorst; R H J A Slart; M W de Haan; F Eerens; H J G M Crijns
Journal:  Neth Heart J       Date:  2014-04       Impact factor: 2.380

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.